hydroxychloroquine has been researched along with Facial Palsy in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rare, well documented, cases of facial palsy have also been described." | 1.33 | [Recurrent facial palsy, primary Gougerot-Sjögren's syndrome and vitamin B12 deficiency]. ( Andrès, E; Blicklé, JF; Brogard, JM; Noel, E; Rousso, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rousso, E | 1 |
| Noel, E | 1 |
| Brogard, JM | 1 |
| Blicklé, JF | 1 |
| Andrès, E | 1 |
| Granel, B | 1 |
| Gaudy, C | 1 |
| Serratrice, J | 1 |
| de Roux-Serratrice, C | 1 |
| Félician, O | 1 |
| Swiader, L | 1 |
| Pache, X | 1 |
| Ceccaldi, M | 1 |
| Balzamo, M | 1 |
| Donnet, A | 1 |
| Manera, L | 1 |
| Raybaud, C | 1 |
| Disdier, P | 1 |
| Weiller, PJ | 1 |
2 other studies available for hydroxychloroquine and Facial Palsy
| Article | Year |
|---|---|
[Recurrent facial palsy, primary Gougerot-Sjögren's syndrome and vitamin B12 deficiency].
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Electromyography; Facial Paralysis; Female; H | 2005 |
[Psychological and behavioral disorders with good outcome in neurosarcoidosis].
Topics: Adult; Antirheumatic Agents; Cognition Disorders; Drug Therapy, Combination; Facial Paralysis; Femal | 2001 |